Zimmer Biomet Holdings Inc (ZBH)
120.17
-1.49
(-1.22%)
USD |
NYSE |
May 06, 14:07
Zimmer Biomet Holdings Free Cash Flow: 1.118B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 1.118B |
December 31, 2023 | 1.204B |
September 30, 2023 | 859.30M |
June 30, 2023 | 1.023B |
March 31, 2023 | 1.143B |
December 31, 2022 | 1.097B |
September 30, 2022 | 1.224B |
June 30, 2022 | 1.210B |
March 31, 2022 | 1.327B |
December 31, 2021 | 1.347B |
September 30, 2021 | 1.442B |
June 30, 2021 | 1.404B |
March 31, 2021 | 902.60M |
December 31, 2020 | 1.093B |
September 30, 2020 | 1.061B |
June 30, 2020 | 1.230B |
March 31, 2020 | 1.346B |
December 31, 2019 | 1.181B |
September 30, 2019 | 1.142B |
June 30, 2019 | 1.045B |
March 31, 2019 | 1.367B |
December 31, 2018 | 1.585B |
September 30, 2018 | 1.609B |
June 30, 2018 | 1.614B |
March 31, 2018 | 1.658B |
Date | Value |
---|---|
December 31, 2017 | 1.426B |
September 30, 2017 | 1.642B |
June 30, 2017 | 1.511B |
March 31, 2017 | 1.435B |
December 31, 2016 | 1.448B |
September 30, 2016 | 1.288B |
June 30, 2016 | 1.037B |
March 31, 2016 | 870.20M |
December 31, 2015 | 682.10M |
September 30, 2015 | 581.40M |
June 30, 2015 | 760.00M |
March 31, 2015 | 815.30M |
December 31, 2014 | 915.60M |
September 30, 2014 | 880.30M |
June 30, 2014 | 912.70M |
March 31, 2014 | 857.90M |
December 31, 2013 | 863.10M |
September 30, 2013 | 910.40M |
June 30, 2013 | 972.50M |
March 31, 2013 | 1.012B |
December 31, 2012 | 1.037B |
September 30, 2012 | 1.188B |
June 30, 2012 | 1.144B |
March 31, 2012 | 1.132B |
December 31, 2011 | 1.063B |
Free Cash Flow Range, Past 5 Years
859.30M
Minimum
Sep 2023
1.442B
Maximum
Sep 2021
1.170B
Average
1.162B
Median
Free Cash Flow Benchmarks
Stryker Corp | 2.858B |
Align Technology Inc | 491.58M |
Edwards Lifesciences Corp | 251.20M |
ResMed Inc | 1.071B |
Globus Medical Inc | 165.22M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 228.00M |
Cash from Investing (Quarterly) | -195.00M |
Cash from Financing (Quarterly) | -50.10M |
Free Cash Flow Per Share (Quarterly) | 0.7779 |
Free Cash Flow to Equity (Quarterly) | 113.10M |
Free Cash Flow to Firm (Quarterly) | 201.13M |
Free Cash Flow Yield | 4.46% |